Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today announces the ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

(Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world ...

Seer also announced a co-marketing and sales agreement with Thermo Fisher Scientific to jointly promote Proteograph alongside ...

DUBLIN--(BUSINESS WIRE)--The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering. The European market for life science tools and reagents and ...

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact ...

On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted third-quarter revenue of $10.59 billion, almost flat year over year, marginally missing the consensus of $10.64 billion. Revenue ...

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 third quarter conference call. My name is Ezra, and I will be your coordinator today. [Operator instructions] I ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28 ...